These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4066635)

  • 1. Biotechnology--here today ... or tomorrow.
    Drees TC
    J Clin Apher; 1985; 2(4):372-4. PubMed ID: 4066635
    [No Abstract]   [Full Text] [Related]  

  • 2. Apheresis in the 1990s.
    Robinson EA
    BMJ; 1993 Sep; 307(6904):578-9. PubMed ID: 8401010
    [No Abstract]   [Full Text] [Related]  

  • 3. Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products.
    Brodniewicz-Proba T
    Blood Rev; 1991 Dec; 5(4):245-57. PubMed ID: 1782484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current topics on therapeutic apheresis technologies: had they already reached a limit?
    Mineshima M
    Ther Apher; 2001 Aug; 5(4):220. PubMed ID: 11724503
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomedical support options for today and tomorrow. Interview by Bill Betts.
    Goldberg E; Ridgway M; Hertzler L; Tackel I; Frappaolo P
    Biomed Instrum Technol; 1997; 31(6):559-68. PubMed ID: 9426893
    [No Abstract]   [Full Text] [Related]  

  • 6. Technology in dermatology: Meeting the challenge today and tomorrow. The Technology Congress Planning Committee.
    Anderson PC; Pearson T
    J Am Acad Dermatol; 1991 Sep; 25(3):572-6. PubMed ID: 1680887
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology management in the health care environment--yesterday, today, and tomorrow: Part 2.
    Short B; Nobel J; Carver M; Tanner L; Ridgway M; Hargest T; Keil O; Stiefel R
    Biomed Instrum Technol; 1990; 24(6):398-403. PubMed ID: 2261578
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange.
    McLeod BC
    Best Pract Res Clin Haematol; 2006; 19(1):157-67. PubMed ID: 16377548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OBTAINING BLOOD AND NONHEMOLYTIC SERUM FROM SMALL LABORATORY ANIMALS AND DOGS].
    SURODEIKINA LN
    Lab Delo; 1964; 10():183-5. PubMed ID: 14141946
    [No Abstract]   [Full Text] [Related]  

  • 10. Technological trends in clinical laboratory science.
    Burtis CA
    Clin Biochem; 1995 Jun; 28(3):213-9. PubMed ID: 7554240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of new technologies for the treatment of diabetic complications: cryoreactive albumin removal apheresis.
    Nosé Y; Ohta K; Suki WN; Takaba J; Miyamoto H
    Artif Organs; 2011 Jan; 35(1):4-8. PubMed ID: 21226744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood products and plasma derivatives].
    Faber JC
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of albumin loss during low-density lipoprotein apheresis.
    Kojima S; Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
    ASAIO Trans; 1990; 36(4):830-3. PubMed ID: 2268488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiology of yesterday, today and tomorrow].
    Beregovich J
    Rev Med Chil; 1996 Mar; 124(3):367-70. PubMed ID: 9008952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnology, economics, and the business of blood.
    Carter TH
    Biotechnology; 1991; 19():3-30. PubMed ID: 1786473
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma fractionation by dead-end membrane filtration: effects of membrane properties and plasma flux.
    Charcosset C; Ding LH; Jaffrin MY
    Biorheology; 1991; 28(1-2):27-37. PubMed ID: 2049530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of human platelets by albumin gradient and gel filtration.
    Timmons S; Hawiger J
    Methods Enzymol; 1989; 169():11-21. PubMed ID: 2716523
    [No Abstract]   [Full Text] [Related]  

  • 18. Albumin-bound substances--a new target in liver failure therapy.
    Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
    [No Abstract]   [Full Text] [Related]  

  • 19. A RAPID TECHNIQUE FOR THE PREPARATION OF CELL-FREE BLOOD SERUM AND PLASMA.
    NISHI HH
    Clin Chim Acta; 1965 Mar; 11():290-2. PubMed ID: 14339031
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Bartlett RH
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.